State-owned Chinese automaker FAW Group is looking at acquiring BMW’s main Chinese partner Brilliance China Automotive Holdings Ltd for about $7.2 billion in a two-stage deal.
Brilliance’s top shareholder Huachen Automotive Group is on the brink of bankruptcy, having defaulted on $1 billion in debt obligations late last year.
Under discussion is FAW's purchase of 30.43 percent of Brilliance owned by Huachen and the 11.89 percent belonging to state-controlled Liaoning Provincial Transportation Investment Group.
FAW would then make a mandatory bid for the rest of Brilliance’s shares.
FAW is considering offering about HK$11 per share for both stages of the deal, representing a 70 percent premium to its HK$6.48 average price over the past month.
Brilliance shares soared by as much as a quarter in value following the news.
To conduct the deal, FAW is looking at setting up an offshore investment vehicle and is inviting other investors to participate.
Brilliance and BMW have 50-50 joint venture, BMW Brilliance Automotive, which accounts for almost all of Brilliance’s profits. BMW plans to boost its stake by another 25 percent in the venture for 3.6 billion euros next year to take control of the venture.
FAW partners with Volkswagen AG and Toyota Motor Corp to build passenger vehicles in China. It also makes heavy-duty trucks under the FAW brand.


TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend 



